Preclinical development of new tetrahydrofuran derivatives targeting the sigma-1 chaperone protein as neuroprotectants in Alzheimer’s disease.

Anavex-1-1666x833.png

Alzheimer’s Association International Conference, July 16-21, 2011, Paris, France

Tangui Maurice, Vanessa Villard, Johann Meunier, Valentine Lahmy, Emeline Keller and Alexandre Vamvakides


View Poster

1/0